US Patent 7446179 CD19-specific chimeric T cell receptor
Patent 7446179 was granted and assigned to City of Hope on November, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7446179 CD19-specific chimeric T cell receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
